Pacific Biomarkers Announces New Chief Scientific Officer
News Jan 03, 2012
Dr. Sethi will succeed the current CSO and co-founder Elizabeth Teng Leary, PhD. Dr. Leary will assume a senior scientific advisory role while remaining active in scientific and business development activities at PBI.
Prior to joining the company, Dr. Sethi trained as a physician at the University of Copenhagen in Denmark (1996). In 2003 he was awarded a PhD in genetic epidemiology at the same institution, and in 2005 he became board certified in chemical pathology by the National Board of Health, Denmark. During 2005-2008 he was a postdoctoral fellow at the National Heart, Lung, and Blood Institute, Pulmonary and Vascular Medicine Branch, National Institutes of Health (NIH), and in 2008 he commenced a clinical chemistry fellowship in the Department of Laboratory Medicine, NIH, overseeing the Immunology Section while continuing his research. Dr. Sethi holds numerous awards and honors in both Denmark and the US, has presented extensively at international scientific meetings, and has published widely in international, peer-reviewed journals. His research has focused on genetic variations related to cardiovascular disease, and, most recently, on composition and function of HDL in patients with ischemic heart disease, and on apo-AI mimetic peptides in animal models of atherosclerosis. Currently, Dr. Sethi is focusing on innovative biomarkers to elucidate the role of HDL in cardiovascular disease.
Dr. Sethi was recently honored by R&D Directions as one of the "Most Notable People in R&D." R&D Directions' selection of the "Most Notable People in R&D" pays tribute to those who have led and made the significant breakthroughs in the discovery and development of drugs that indelibly change the ways in which particular diseases are treated.
"We are extremely pleased that a physician-scientist of Dr. Sethi's stature will be our CSO," commented Ron Helm, the company's CEO. "Amar is one of the leading scientists in the field and his work continues to reinforce our standing and reputation in the industry as the premier provider of esoteric testing services to pharma and diagnostic companies in the areas of cardiovascular, metabolic, and bone and joint diseases."
Protein Discovery Could Lead to Better Diagnosis of StressNews
Researchers have found a protein that is present in people while they are in stressful situations. The discovery could lead to identifying new ways to predict, diagnose and treat stress.READ MORE
Tiny “Tornado” Boosts Performance of Electrospray Ionization Mass SpectrometryNews
Known as Dry Ion Localization and Locomotion (DRILL), the new device creates a swirling flow that can separate electrospray droplets depending on their size.READ MORE
Molecular Mechanism That Enable Neuronal Connections to Change With Development DiscoveredNews
Researchers from King's College London have discovered a molecular mechanism that enables neuronal connections to change through experience, thus fuelling learning and memory formation.READ MORE
Comments | 0 ADD COMMENT
11th Edition of International Conference on Proteomics 2018
Mar 22 - Mar 23, 2018
EMBO Workshop: Integrating Systems Biology: From Networks to Mechanisms to Models
Apr 15 - Apr 17, 2018
EMBL Course: Introduction to Metabolomics Analysis
Mar 20 - Mar 23, 2018